Aspirin-free Strategy With Ticagrelor in Patients With a Myocardial Infarction Treated Medically Alone

A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 2570 participants.

Also called NCT07257198

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 2,570 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07257198
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Canada (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT07257198. Randomized; quadruple masking; primary purpose treatment. Start 2026-03-03 (actual); primary completion 2030-01-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Aspirin-free Strategy With Ticagrelor in Patients With a Myocardial Infarction Treated Medically Alone
Acronym
PANTHEON
Condition
NSTEMI - Non-ST Segment Elevation MI
Condition
STEMI (ST Elevation MI)
Intervention (Drug)
Ticagrelor + placebo
Intervention (Drug)
Ticagrelor + aspirin
Lead sponsor
Montreal Heart Institute (class: other)

Record details

Record id
cardio:ct-nct07257198
Content hash
ed44a79fd0cca5069b745be25cead328499be0ca50ca0818ab04b9e74dd6515a